In breast cancer cells, TGFβ-YAP/TAZ-TEAD signaling is crucial in driving late-stage metastatic phenotypes via Smad2/3-induced NERG1 and UCA1 transcription [72]. This evidence concerns the gene SMAD2 and breast cancer.